Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07874945Phase 1Not yet recruiting
Phase 1 trial of human insulin in obesity and insulin resistance (IR) (2 arms), sponsored by University of Missouri. Primary endpoint: Forearm blood flow at 5 minutes. Planned start Dec 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07874945.